Tema Oncology ETFCANCETF

13F holders, Q4 2025 (December 31)
6holders
2new positions
3sold out
$34.72avg. 13F price*

At the end of Q4 2025, 6 institutions reported holding Tema Oncology ETF (CANC) in their 13F filings, unchanged from Q3 2025. 2 opened new positions and 3 sold out. The largest holders were Thrivent Financial for Lutherans ($50.7M), Willow Financial LLC ($2.4M) and Jane Street Group, LLC ($1.1M).

Company
Tema Oncology ETF
Filed as
TEMA ETF TRUST (Q4 2025)
CUSIP
87975E701
Latest filing quarter
Q2 2026

History

Number of 13F holders

051015 Q1 2024: 3Q1 2024Q2 2024: 4Q2 2024Q3 2024: 5Q3 2024Q4 2024: 3Q4 2024Q1 2025: 6Q1 2025Q2 2025: 5Q2 2025Q3 2025: 6Q3 2025Q4 2025: 6Q4 2025Q1 2026: 12Q1 2026Q2 2026: 14Q2 2026

Total Exit/New Position Q3 2025 → Q4 2025

InstitutionsTotal Value
New Positions2$1.4M
Exits3$649K

All 13F filers, Q3 2025 → Q4 2025: 1,353,891 shares bought and 22,594 shares sold, net +1,331,297 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 6 holders

Thrivent Financial for Lutherans 0.09% Add +891.1% 1,461,649 $50.7M
Willow Financial LLC 2.48% — 70,294 $2.4M
Jane Street Group, LLC 0.00% New 31,696 $1.1M
LPL Financial LLC 0.00% New 8,018 $278K
TD Capital Management LLC 0.00% No change 376 $13K
Osaic Holdings, Inc. 0.00% No change 370 $13K

"% of holder's portfolio" is CANC's weight in each manager's 13F, not the share of Tema Oncology ETF the manager owns.